• Estrogenic compounds/pesticides and their impact on human health
• Role of nutrition in altering gene expression epigenetically
• Disproportionate chemical burden in women and minorities
• Environmental Justice and Social Justice
• Educating community around chemical hazards and exposure hazards
• Occupational health
• Atrazine/Triazine and Breast, Prostate, and Uterine Cancer
My research focuses on risk perception, communication, and management. More specifically, I study mental models of hazardous processes and their role in decision-making under uncertainty in environmental, health and technology policy contexts.
I am trained as a child psychiatric epidemiologist and view mental health through a public health lens. Depression and other mental health conditions are the most prominent contributors to disease burden in terms of years of life lost to disability worldwide. The onset of mental health conditions is typically during adolescence.
My research identifies social, economic, behavioral factors that contribute to child and adolescent mental health problems. I teach quantitative research methods to public health practice students at UW and to mental health research trainees at the University of Nairobi. I contribute to the development of school-based early intervention programs designed to support students who are experiencing emotional distress. In Malawi I have worked to raise awareness of child emotional health needs and to support community-based child psychosocial support programming.
Dr. Anna Wald is the director of the UW Virology Research Clinic and a UW professor of medicine, epidemiology and laboratory medicine. She is board certified in internal medicine and infectious diseases and a fellow of American College of Physician and Infectious Diseases Society of America.
Dr. Wald’s area of specialty is clinical virology, in particular herpes virus infections. She has been practicing at UW since 1989.
Annette Ghee has been focused on population health for over 15 years. She has connections to two UW departments. She is an Affiliate Assistant Professor in the Department of Global Health (UW DGH) and holds a PhD from the Department of Epidemiology.
Dr. Ghee is the Director for Evidence supporting Global Health at World Vision. She leads a team of M&E professionals who support a broad range of community health programs in more than 70 developing countries. While at World Vision, she has co-led a global mobile health (mHealth) initiative which now includes 22 deployments in 16 countries.
Until now, her affiliation with UW DGH has focused on service as a mentor and committee member for MPH and MD, MPH candidates.
As an epidemiologist and research professor, I have focused my entire career on understanding, evaluating and developing interventions to improve the health of populations in communities in the US and globally. While the methods I utilize can address most health environments, I am primarily involved in studies of aging and risk factors related to hypertension, diabetes, heart disease, stroke, dementia and cognitive decline. While I remain active in long-term longitudinal cohorts supported by NIH to study risk factors for clinical and subclinical cardiovascular disease including ethnic disparities, I am currently collaborating on projects addressing non-communicable diseases in low and middle income countries (LMICs) including Nepal, Cambodia, Kenya and Malawi.
Decreasing opiod use, increasing chronic pain management and palliative care
I have directed two large long-term randomized trials in school-based smoking prevention (Hutchinson Smoking Prevention Project, 1984 – 2000) and youth smoking cessation (Hutchinson Study of Youth and Young Adult Smoking, 2000 – 2016). These trials were in collaboration with 40 school district, and 50 high schools, in the State of Washington. Long-term involvement and cooperation of highly supportive communities statewide was fundamental to the success of both these trials.
My work has focused on population health – in terms of research, community, and policy initiatives – for the last 25 years. My research, specifically, has addressed questions about older women’s health promotion and disease prevention. The large, landmark Women’s Health Initiative (WHI) Clinical Trial and Observational Study began data collection in 1993 and continues in a long-term follow-up today, although its main clinical trial closed out in 2005. As a co-investigator at the NIH/NHLBI-funded Clinical Coordinating Center for the WHI (Prentice/Anderson, PI), I have been involved in developing scientific protocols and collaborative analyses with scientists nationally and internationally, coordinating a wide range of procedures and communications with clinical sites and their participants across the United States, and encouraging the engagement of established and early-career scientists in our ongoing work. The WHI has had a major impact on the health of women globally, particularly in terms of the ground-breaking findings about the risk-benefit balance of postmenopausal hormones, but its reach has extended to diverse aspects of women’s health (e.g., diet, use of supplements, quality of life, racial/ethnic considerations, environmental exposures, genomics) and establishing an effective infrastructure for coordinating large population initiatives with appropriate scientific rigor.
My experience with the WHI supported my work in the collaborative development and implementation of the original protocols for the NIA-funded MsFLASH (Menopausal Strategies: Finding Lasting Answers for Symptoms & Health) — a study of short-term treatments for menopausal systems in women at five study centers across the United States (LaCroix, PI), as well as scientific analyses, implementation protocols, and performance-monitoring for the Enhancing Connections Program (Helping the Mother with Breast Cancer Support her Child; Lewis, PI) – an intervention study across six states.
In terms of community and policy initiatives, I recently completed a Global Innovation Fund project with Dr. Nancy Hooyman (PI, from Social Work), “Promoting Community-based Eldercare in Chongqing China.” In addition, the de Tornyay Center for Healthy Aging (which I direct) is currently launching a “Wellness Network” – an initiative that will support partnerships with communities, facilities, and agencies to create a data repository of information about the health of older adults in our region that serves research, student experiences, and data-driven services for older adults. have served on Washington State boards and task forces in support of the health of our vulnerable populations (e.g., Certified Professional Guardianship Board, Adult Family Home Quality Assurance Panel, Older Adult Falls Prevention Action Plan Advisory Group), as well as the community development steering committee, Imagine Lake City — a planning grant funded by Wells Fargo Foundation to support community development.
Statistical methodology for clinical trials data; analysis of data from clinical trials; statistical analysis with missing data; longitudinal data analysis; statistical methods for AIDS and STD data.
We conduct research on interventions to promote nurturing early parent child relationships in families with infants birth to five that are living in adverse circumstances. Families may be experiencing adult mental health and substance use, poverty, immigration and refuge status, and/or child maltreatment and neglect.
Basia Belza, PhD, RN, FAAN is The Aljoya Endowed Professor in Aging in the School of Nursing and an investigator with the Health Promotion Research Center at University of Washington. She is the lead of the CDC-funded Coordinating Center for the Healthy Brain Research Network. Her scholarship focuses on improving the health of older adults through dissemination initiatives with a focus on physical activity interventions.
I have worked in population health since 1987, first in the National Institute of Public Health-Mexico, and since 2011 at the Institute for Health Metrics and Evaluation. My work has concentrated in the areas of maternal and child health, obesity and physical activity, and program evaluation. In this area, I contributed to the evaluation of the anti-poverty program Progresa/Oportunidades in Mexico, and at present in the evaluation of the Mesoamerican Health Initiative, a result-based finance project aiming to improve maternal and child health in poor population in Mesoamerica.
Most of my work has focused on use of population-based health data.
Beth E. Rivin, M.D., M.P.H. is a pediatrician who has focused on global health for over 30 years. She has been actively engaged in the academic and practice area of global health and justice. She is Research Associate Professor of Law, Director of the Global Health and Justice Project in the Center for Law, Science and Global Health. She has appointments in the Schools of Medicine and Public Health in the Departments of Global Health and Bioethics and Humanities. She has had ongoing projects in Indonesia since 1999 and currently has an extended appointment as Visiting Professor at University of Gadjah Mada School of Medicine, Center for Bioethics and Medical Humanities in Jogjakarta, Indonesia, where she was a Senior Fulbright Scholar in 2011-2012. Currently, she is Principal Investigator on two projects focused on building bioethics capacity in university medical schools in South Asia and the Middle East. Her leadership roles include Chair of the Human Right to Family Planning Initiative, Senior Global Health and Ethics Advisor at East West Management Institute, Advisory Board Member of the Centre for Ethics in Medicine and Society in Melbourne, Australia, and Co-Chair of International Collaborations in the Asia Pacific Consortium for Bioethics.
Betty Bekemeier is associate professor at the University of Washington (UW) School of Nursing and Director of the UW School of Public Health’s Northwest Center for Public Health Practice. She is a distinguished public health systems researcher and has worked extensively toward improving the effectiveness of our prevention systems and the related public health workforce.
She has led numerous studies regarding local health department (LHD) services and their impact on population-level health outcomes and health disparities. Dr. Bekemeier is PI of the Public Health Activities and Services Tracking (PHAST) Study, a highly regarded, growing database of uniquely detailed and linked data regarding LHD services. Her PHAST research has supported several important studies, and involves an interdisciplinary team of investigators.
Dr. Bekemeier’s studies on change, variation, and outcomes regarding public health systems have been conducted in partnership with public health practice leaders and have been immediately relevant to addressing current policy issues that relate to population health. Her recent study on relationships between LHD expenditures and local rates of low birth weight was awarded AcademyHealth’s 2014 Public Health System Research Article of the Year.
Dr. Bekemeier is a national public health and nursing leader, having served in significant leadership positions in organizations that include the American Public Health Association and the American Academy of Nursing.
Dr. Beverly Green is a family physician and associate investigator at Group Health and Group Health Research Institute. Her areas of interest include population based screening within organized health care and safety net settings, improving the care of chronic conditions such as hypertension, and leveraging technology to optimize the reach and effectiveness of evidence-based health care. She is also a Clinical Associate Professor in the University of Washington Medical School Department of Family Medicine.
Bill enjoys applying his clinical and technology backgrounds to address information management problems in clinical care, public health, and global health. He and his staff build information systems that are used both within academics, to understand and evaluate new approaches and methods, and outside of academics, to deliver real world value in health care.
He received his MD from the University of California, San Francisco, a Master of Health Sciences from the University of California, Berkeley, and a BSEE in Electrical Engineering from Tufts University. He completed a residency in Emergency Medicine at the University of Arizona, and the Royal Brisbane Hospital, Queensland, Australia, after which he joined the faculty in the Emergency Medicine at University of Washington. While at UW, he was awarded a F38 “mid-career” fellowship from the National Institutes of Health in Applied Medical Informatics. Currently he is a Professor in Health Informatics and Global Health, jointly appointed in UW’s Schools of Nursing, Medicine, and Public Health, and directs the UW Clinical Informatics Research Group.
My work primarily focuses on the role and drivers of spatio-temporal variation in infectious disease transmission dynamics. This has lead me to a relatively divers set of pathogens that I study. For the past 5 years I have focused on mosquito-borne pathogens transmission dynamics at relatively small scales (specifically, malaria, dengue, West Nile virus, chikungunya, and more recently Zika). Since joining IHME, I have expanded this focus to incorporate global variation in incidence and prevalence of lower respitory infections and diarrhea as part of the ‘Geospatial’ and the Global Burden of Disease teams.
Bonnie Duran Dr.PH (mixed race Opelousas/Coushatta descendent) is an associate professor in the Schools of Social Work and School of Public Health at the University of Washington, and is the Director of the Center for Indigenous Health Research at the Indigenous Wellness Research Institute (http://health.iwri.org ). She has worked in public health research, evaluation and education among Native Americans and other communities of color for over 35 years.
Dr. Duran is currently the Principal Investigator of 2 NIH funded research projects in “Indian Country”. Working with the American Indian Higher Education Consortium and 25 Tribal Colleges, she is conducting 2 studies; (a) a psychiatric epidemiology prevalence and correlates study (N=3,200, and (b) a TCU-cultural adaptation of Brief Alcohol Screening and Intervention for College Students (BASICS). Dr. Duran is also Co-PI of an NIMH funded R25 HIV and mental health research training program. Her past work includes partnering with the Navajo Nation, Indian Health Service and Indigenous Community Based Organizations on frontier rural projects aimed at improving health services, and developing culture-centered health promotion.
The overall aims of Dr. Duran’s research are to work in partnership with communities to design public health treatment and prevention efforts that are empowering, culture-centered, accessible and sustainable and that have maximum public health impact. She has many publications including articles in peer-reviewed journals, book chapters and books.
Dr. Duran is on the editorial board of Health Education & Behavior and the Progress in Community Health Partnerships. She is an Advisory Board Member of RISE for Boys and Men of Color, Foundation Executive Alliance.
Bonnie Duran is also a Buddhist mindfulness practitioner and teacher. She teaches long and short mindfulness retreats at the Insight Meditation Society (IMS dharma.org) in Massachusetts and at Spirit Rock Meditation Center (SRMC Spiritrock.org) in California.
Dr. Wagenaar’s research, implementation, and service work focuses on supporting equitable public-sector health systems and policies globally. He has particular interests in improving the prevention and treatment of mental health disorders in low-and middle-income countries. He has previously worked in Cameroon, Haiti, and Malawi.
In his current role working with Health Alliance International, a Center of the Department of Global Health, he provides technical support to a number of health systems, operations research, and implementation science projects in Mozambique, primarily focused on improving government primary healthcare and the quality and use of health information system data for decision-making and health evaluations. He is trained as an Epidemiologist and has specific expertise in quasi-experimental designs and time-series analyses.
Dr. Guthrie, PhD, is an epidemiologist and Assistant Professor of Global Health and Epidemiology at the University of Washington. His specific research interests focus on improving engagement in care among people living with HIV.
Dr. Guthrie has NIH-funded research projects based in Nairobi, Kenya that are evaluating interventions to improve linkage and retention in HIV/AIDS care, expedite treatment initiation, and reduce mortality. His research includes both randomized intervention trials as well as mixed methods and implementation science approaches to evaluate interventions that are tailored to achieve both high effectiveness and acceptability.
Dr. Guthrie is an instructor in “Advanced Epidemiologic Methods I & II” (Epi 515 and Epi 516) and lecturer in the “Principles of HIV Research” taught in Nairobi, and is the co-director and lecturer in the Epidemiology/Biostatistics module of a fellowship program that trains students in HIV program management, health economics, and health informatics, in collaboration with the University of Nairobi.
I was trained as a child health psychologist and conduct research and provide care and service to the community with a focus on obesity treatment and prevention. My population health interests revolve around policy, systems, and environment changes guided by community engagement to improve health equity by providing opportunities for healthy eating and physical activity across the lifespan. I have the privilege to work with community partners and other investigators and practitioners to address health disparities.
Bruce M. Psaty, MD, PhD is a Professor of Medicine, Epidemiology, and Health Services; Co-Director of the UW Cardiovascular Health Research Unit; an Investigator at Group Health Research Institute; and a practicing general internist at Harborview. His research interests include cardiovascular epidemiology, epidemiological methods, myocardial infarction, stroke, hypertension, diabetes, drug safety, pharmacoepidemiology, genetics, genomics, and pharmacogenetics.
Dr Psaty is the principal investigator on several large epidemiologic studies and has had major roles at the coordinating centers of NIH-funded multi-center studies, including the Cardiovascular Health Study and the Multi-Ethnic Study of Atherosclerosis. In these settings and others, he has used case-control, cohort, clinical-trial and meta-analytic methods to evaluate the risks and benefits of a variety of medications, including drug-gene interactions that may influence their risk-benefit profile. Recently, Dr Psaty collaborated with investigators from other national and international cohort studies to establish the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium, which has published more than 250 meta-analyses of genome-wide association studies. I
n 2005, he received the UW Outstanding Public Service Award for his work on drug safety. Elected memberships include American Epidemiological Society, Association of American Physicians, the Institute of Medicine, now the National Academy of Medicine, and fellow of the American Heart Association. In 2013, the AHA designated Dr Psaty a Distinguished Scientist. Currently, Dr Psaty serves as chair of the US Food and Drug Administration Science Board and a member of the National Heart, Lung and Blood Institute Advisory Council. With more than 800 publications, he was named one of the Reuters’ highly cited author in 2014, 2015, and 2016.
I trace the presence, pathways and sources of anthropogenic toxic metals distributed throughout the environment.
My work uses the stable metal isotope composition (as well as concentration) of metals such as Pb, Cu, Zn and potentially others to fingerprint the source and distribution of the anthropogenic component. An example is identifying the source and distribution of Pb emitted from the Teck-Cominco smelter in Canada and distributed by wind and water onto the Colville Indian Reservation.